Table 1 Baseline clinical characteristics of the participants or patients study participants
Variables | |
|---|---|
No. patients | 57 |
Sex, male/female | 39/18 |
Age (years) | 67.2 ± 7.7 |
BMI (kg/m2) | 25.4 ± 4.2 |
Duration of diabetes (years) | 11.5 ± 9.6 |
Fasting plasma glucose (mg/dL) | 134.7 ± 30.7 |
HbA1c (%) | 7.3 ± 1.0 |
Long-term data | |
 No. HbA1c measurements in 2 years (times/2 years) | 14.8 ± 4.7 |
 Two-year mean HbA1c (%) | 7.2 ± 1.0 |
 HbA1c CV (%) | 0.049 (0.029–0.080) |
 HbA1c SD (%) | 0.33 (0.18–0.62) |
 Adjusted HbA1c SD (%) | 0.32 (0.18–0.59) |
Short-term data | |
 CGM mean glucose (mg/dL) | 154.5 ± 28.8 |
 CGM CV (mg/dL) | 23.6 ± 7.1 |
 CGM SD (mg/dL) | 36.7 ± 13.2 |
Hypertension, n (%) | 42 (74) |
Blood pressure (mmHg) | |
 Systolic | 124.6 ± 17.0 |
 Diastolic | 77.1 ± 9.4 |
Heart rate (beats/min) | 69.3 ± 11.8 |
Dyslipidemia, n (%) | 51 (89) |
Lipid profile (mg/dL) | |
 Triglycerides | 115 (100–175) |
 LDL-cholesterol | 111.0 ± 30.2 |
 HDL-cholesterol | 52.8 ± 15.5 |
BRS (msec/mmHg) | 7.6 ± 2.7 |